Click Here for 5% Off Your First Aladdin Purchase!

CM4620 , CAS No.C608608, Channel blocker of Orai1;Channel blocker of Orai2

  • Moligand™
Item Number
C608608
Grouped product items
SKUSizeAvailabilityPrice Qty
C608608-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
C608608-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,001.90

Basic Description

SynonymsCM-4620|1713240-67-5|Zegocractin|CM4620|N-(5-(6-Chloro-2,2-difluorobenzo[d][1,3]dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide|Zegocractin [INN]|CM 4620|CHEMBL4753998|564AW1RR37|N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-fluoro
Specifications & PurityMoligand™
GradeMoligand™
Action TypeCHANNEL BLOCKER
Mechanism of actionChannel blocker of Orai1;Channel blocker of Orai2

Associated Targets

ORAI1 Tchem Calcium release-activated calcium channel protein 1 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

STIM1 Tbio Stromal interaction molecule 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ORAI2 Tchem Protein orai-2 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-fluoro-6-methylbenzamide
INCHI InChI=1S/C19H11ClF3N3O3/c1-9-3-2-4-12(21)17(9)18(27)26-16-8-24-13(7-25-16)10-5-14-15(6-11(10)20)29-19(22,23)28-14/h2-8H,1H3,(H,25,26,27)
InChi Key QQMKTHUGOQDEIL-UHFFFAOYSA-N
Canonical SMILES Clc1cc2OC(Oc2cc1c1ncc(nc1)NC(=O)c1c(C)cccc1F)(F)F
Isomeric SMILES CC1=C(C(=CC=C1)F)C(=O)NC2=NC=C(N=C2)C3=CC4=C(C=C3Cl)OC(O4)(F)F
PubChem CID 122507647

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Gerasimenko JV, Gryshchenko O, Ferdek PE, Stapleton E, Hébert TO, Bychkova S, Peng S, Begg M, Gerasimenko OV, Petersen OH.  (2013)  Ca2+ release-activated Ca2+ channel blockade as a potential tool in antipancreatitis therapy..  Proc Natl Acad Sci USA,  110  (32): (13186-91).  [PMID:23878235]
2. Gukovskaya AS, Pandol SJ, Gukovsky I.  (2016)  New insights into the pathways initiating and driving pancreatitis..  Curr Opin Gastroenterol,  32  (5): (429-435).  [PMID:27428704]
3. Wen L, Voronina S, Javed MA, Awais M, Szatmary P, Latawiec D, Chvanov M, Collier D, Huang W, Barrett J et al..  (2015)  Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models..  Gastroenterology,  149  (2): (481-92.e7).  [PMID:25917787]

Solution Calculators